Search

everythinglearnresearchcommunity

for

Search:↓

Phenytoin and spironolactone help prevent hair loss from chemotherapy by reducing stress and inflammation.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Intermittent compression therapy is safe and doesn't harm tissue.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Vitamin E affects liver metabolism, enhancing stress resistance, reducing blood clotting, and altering hormone processing.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Paclitaxel chemotherapy causes premature aging and damage to hair follicles, potentially leading to permanent hair loss.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

PRP with microneedling is generally safe but can cause minor side effects like scalp itching, temporary hair shedding, and swollen lymph nodes.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Finasteride may reduce prostate tumor cell invasion and spread.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Pterostilbene significantly reduces prostate enlargement and has strong antioxidant effects.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

The drug combination was safe and showed promise in treating advanced tumors.

Heptaminol may cause hair lightening in hemodialysis patients.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Finasteride significantly reduces prostate cancer risk.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

The treatment is safe and shows promise for metastatic breast cancer.